Metformin

$0.00005074

-$0.00000269

-5.03%

• Today

Info

Symbol

Met

Network

Solana

Market Cap

$51K

Total Supply

999.86M

Circulating Supply

999.86M

Holders

2,570

Volume (24h)

$228.60

+130.17%

Trades (24h)

12

-25.00%

Traders (24h)

8

-20.00%

About

Our team of three experienced medical doctors, with a strong track record of publications in high-impact SCI and SCI-Expanded journals, is embarking on an ambitious research project to investigate the longevity benefits of metformin. Metformin, widely recognized for its efficacy in managing type 2 diabetes, has drawn growing interest for its potential to influence aging and chronic disease pathways. Preclinical and clinical studies suggest that metformin may play a pivotal role in modulating mechanisms associated with aging, opening new avenues for research in longevity science.

Website

X

FAQ

The market capitalization of Met is $51K as of Jun 12, 2025.

Market capitalization is calculated by multiplying the current price of Met by its circulating supply. It reflects the overall value of the token in the market and helps gauge its relative size compared to other cryptocurrencies.

The daily trading volume of Met is $228.60 as of Jun 12, 2025.

Trading volume can fluctuate based on market conditions, investor activity, and overall demand for Met.

The total supply of Met is 999.86M.

The circulating supply, which represents the number of Met currently available in the market, is 999.86M as of Jun 12, 2025.

Met can be bought and traded on a variety of cryptocurrency platforms, including Phantom!

Pricing information is provided for informational purposes only and is not financial advice. Market data is provided by third parties and Phantom makes no representation as to the accuracy of the information.

Buy Metformin with the Mobile App

Scan the QR Code above to download Phantom and buy, sell, and manage your crypto on the go.

Get the Phantom Mobile App

Trending Tokens

Traveling To All 50 States LIVE

Pricing information is provided for informational purposes only and is not financial advice. Market data is provided by third parties and Phantom makes no representation as to the accuracy of the information.